References
- Kleinman C S, Donnerstein R L. Fetal echocardiography. A tool for evaluation of in utero cardiac arrhythmias and monitoring of in utero therapy: Analysis of 71 patients. Am J Cardiol 1983; 51: 237–243
- Ross B A. Atrioventricular block. The science and practice of pediatric cardiology, A Garson, Jr, J T Bricker, D G McNamara. Lea and Febiger, Philadelphia, PA 1990; 1803
- McCue C M, Mantakas M E, Tingelstad J B, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977; 56: 82–90
- Waltuck J, Buyon J P. Autoantibody-associated congenital heart block: Outcome in mothers and children. Ann Intern Med 1994; 120: 544–551
- Scott J S, Maddison P J, Taylor P V, Esscher E, Scott O, Skinner R P. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983; 309: 209–212
- Buyon J P, Hiebert R, Copel J A, Craft J, Friedman D, Katholi M, Lee L A, Provost T T, Reichlin M, Rider L, et al. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658–1666
- Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni M P, Muscarà M, Vignati G, Stramba-Badiale M, Catelli L, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis Rheum 2001; 4: 1832–1835
- Litsey S E, Noonan J A, O'Connor W N, Cottrill C M, Mitchell B. Maternal connective tissue disease and congenital heart block: Demonstration of immunoglobulin in cardiac tissue. N Engl J Med 1985; 312: 98–100
- Taylor P V, Scott J S, Gerlis L M, Esscher E, Scott O. Maternal antibodies against fetal cardiac antigens in congenital complete heart block. N Engl Med J 1986; 315: 667–672
- Machado M V, Tynan M J, Curry P V, Allan L D. Fetal complete heart block. Br Heart J 1988; 60: 512–515
- Jaeggi E, Hamilton R M, Silverman E D, Zamora S A, Hornberger L K. Outcome of children with fetal, neonatal or childhood diagnosis of isolated complete heart block (CHB): A single institution's experience of 30 years. J Am Col Cardiol 2002; 39: 130–137
- Eronen M, Siren M K, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000; 106: 86–91
- Schmidt K G, Ulmer H E, Silverman N H, Kleinman C S, Copel J A. Perinatal outcome of fetal complete atrioventricular block: A multicenter experience. J Am Coll Cardiol 1991; 91: 1360–1366
- Groves A M, Allan L D, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996; 75: 190–194
- Ayres N A. Fetal cardiology. The science and practice of pediatric cardiology. 2nded, A Garson, J T Bricker, D J Fisher, S R Neish. Williams and Wilkins, Baltimore, USA 1998; 2294
- Breur J M, Gooskens R H, Kapusta L, Stoutenbeek P, Visser G H, van den Berg P, Meijboom E J. Neurological outcome in isolated congenital heart block and hydrops fetalis. Fetal Diagn Ther 2007; 22: 457–461
- Salomonsson S, Dörner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002; 46: 1233–1241
- Buyon J P, Winchester R J, Slade S G, Arnett F, Copel J, Friedman D, Lockshin M D. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993; 36: 1263–1273
- Gorden P, Khamashta M, Rosenthal E, Simpson J M, Sharland G, Brucato A, Franceschini F, De Bosschere K, Meheus L, Meroni P L, et al. Anti-52kD Ro, anti-60kD Ro and anti-La antibody profiles in neonatal lupus, Abstract
- Larroche J C, Aubry M C, Narcy F. Intrauterine brain damage in nonimmune hydrops fetalis. Biol Neonate 1992; 61: 273–280
- Laneri G G, Claassen D L, Scher M S. Brain lesions of fetal onset in encephalopathic infants with nonimmune hydrops fetalis. Pediatr Neurol 1994; 11: 18–22
- Oudijk M A, Gooskens R H, Stoutenbeek Ph, de Vries L S, Visser G H, Meiboom E J. Neurological outcome of children who were treated for fetal tachycardia complicated by hydrops. Ultrsound Obstet Gynecol 2003 in press
- Breur J M, Udink ten Cate F E, Kapusta L, Cohen M I, Crosson J E, Boramanand N, Lubbers L J, Friedman A H, Brenner J I, Vetter V L, et al. Pacemaker therapy in isolated congenital complete atrioventricular block. Pacing Clin Electrophysiol 2002; 25: 1685–1691
- Schmidt K G, Ulmer B E, Silverman N H, Kleinman C S, Copel J A. Perinatal outcome of fetal complete atrioventricular block: A multicenter experience. J Am Coll Cardiol 1991; 17: 1360–1366
- Taylor-Albert E, Reichlin M, Toews W H, Overholt E D, Lee L A. Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: Case reports, autoantibody analysis, and management. Pediatrics 1997; 99: 733–735
- Udink ten Cate F E, Breur J M, Cohen M I, Boramanand N, Kapusta L, Crosson J E, Brenner J I, Lubbers L J, Friedman A H, Vetter V L, et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: Early and long-term risk in children. J Am Coll Cardiol 2001; 37: 1129–1134
- Eronen M, Heikkila P, Teramo K. Congenital complete heart block in the fetus: Hemodynamic features, antenatal treatment, and outcome in six cases. Pediatr Cardiol 2001; 22: 385–392
- Saleeb S, Copel J, Friedman D, Buyon J P. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block. Arthritis Rheum 1999; 42: 2335–2345
- Reinisch J M, Simon N G, Karow W G, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978; 202: 436–438
- Huang W L, Beazley L D, Quinlivan J A, Evans S F, Newnham J P, Dunlop S A. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol 1999; 94: 213–218
- Visser G H. Antenatal administration of glucocorticosteroids in threatened preterm birth. Ned Tijdschr Geneeskd 2001; 145: 2517–2521
- van Bel F. Administration of glucocorticosteroids to premature infants: Increasing evidence of adverse effects. Ned Tijdschr Geneeskd 2001; 145: 2521–2525
- Benediktsson R, Lindsay R S, Noble J, Seckl J R, Edwards C R. Glucocorticoid exposure in utero: New model for adult hypertension. Lancet 1993; 341: 339–341
- Breur J M, Visser G H, Kruize A A, Stoutenbeek P, Meijboom E J. Treatment of fetal heart block with maternal steroid therapy: Case report and review of the literature. Ultrasound Obstet Gynecol 2004; 24: 467–472
- Jaeggi E T, Fouron J C, Silverman E D, Ryan G, Smallhorn J, Hornberger L K. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004; 110: 1542–1548
- Walkinshaw S A, Welch C R, McCormack J, Walsh K. In utero pacing for fetal congenital heart block. Fetal Diagn Ther 1994; 9: 183–185
- Assad R S, Zielinsky P, Kalil R, Lima G, Aramayo A, Santos A, Costa R, Marcial M B, Oliveira S A. New lead for in utero pacing for fetal congenital heart block. J Thorac Cardiovasc Surg 2003; 126: 300–302